ADURO BIOTECH INC's ticker is ADRO and the CUSIP is 00739L101. A total of 87 filers reported holding ADURO BIOTECH INC in Q4 2016. The put-call ratio across all filers is 0.51 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $513,000 | +51.8% | 128,965 | +0.8% | 0.00% | – |
| Q4 2018 | $338,000 | -89.5% | 127,929 | -70.9% | 0.00% | -100.0% |
| Q3 2018 | $3,230,000 | +35.9% | 439,356 | +29.4% | 0.00% | -50.0% |
| Q2 2018 | $2,376,000 | +51.7% | 339,409 | +101.5% | 0.00% | +100.0% |
| Q1 2018 | $1,566,000 | +65.0% | 168,416 | +33.1% | 0.00% | 0.0% |
| Q4 2017 | $949,000 | -17.0% | 126,577 | +17.9% | 0.00% | 0.0% |
| Q3 2017 | $1,143,000 | -5.5% | 107,341 | +1.1% | 0.00% | 0.0% |
| Q2 2017 | $1,210,000 | +14.4% | 106,153 | +7.8% | 0.00% | 0.0% |
| Q1 2017 | $1,058,000 | -9.2% | 98,443 | -3.7% | 0.00% | 0.0% |
| Q4 2016 | $1,165,000 | -36.3% | 102,203 | -30.6% | 0.00% | 0.0% |
| Q3 2016 | $1,830,000 | +28.8% | 147,227 | +17.1% | 0.00% | 0.0% |
| Q2 2016 | $1,421,000 | +302.5% | 125,683 | +355.9% | 0.00% | – |
| Q1 2016 | $353,000 | -75.4% | 27,570 | -46.0% | 0.00% | -100.0% |
| Q4 2015 | $1,437,000 | +169.1% | 51,060 | +85.2% | 0.00% | – |
| Q3 2015 | $534,000 | +58.0% | 27,570 | +147.1% | 0.00% | – |
| Q2 2015 | $338,000 | – | 11,158 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 745,886 | $8,503,000 | 1.71% |
| OAK RIDGE INVESTMENTS LLC | 915,134 | $10,433,000 | 0.34% |
| Rock Springs Capital Management LP | 415,000 | $4,731,000 | 0.32% |
| CLOUGH CAPITAL PARTNERS L P | 326,400 | $3,721,000 | 0.25% |
| NJ State Employees Deferred Compensation Plan | 53,300 | $608,000 | 0.12% |
| GLOBEFLEX CAPITAL L P | 36,200 | $413,000 | 0.10% |
| Vident Investment Advisory, LLC | 65,874 | $751,000 | 0.09% |
| Virtus ETF Advisers LLC | 23,109 | $263,000 | 0.08% |
| Foundry Partners, LLC | 77,452 | $883,000 | 0.04% |
| Artal Group S.A. | 100,000 | $1,140,000 | 0.02% |